Breast Carcinoma with Choriocarcinomatous Differentiation; a Rare Case
- Resource Type
- Authors
- Ozden Altundag; Arzu Oguz; Nadire Kucukoztas; Omer Dizdar; Samed Rahatli
- Source
- European Journal of Case Reports in Internal Medicine, Vol 1, Iss 1 (2014)
- Subject
- Oncology
medicine.medical_specialty
Poor prognosis
Breast carcinoma, choriocarcinomatous differentiation, chemiotherapy
business.industry
Adjuvant chemotherapy
lcsh:R
Rare entity
Clinical course
lcsh:Medicine
Still Disease
Disease
Internal medicine
Rare case
Internal Medicine
Medicine
business
Breast carcinoma
- Language
- ISSN
- 2284-2594
Objectives : Breast carcinoma with choriocarcinomatous differentiation is a rare entity, generally presenting with high-grade disease and an aggressive clinical course with overall survival of less than a year Case : A 69-year-old woman with a diagnosis of pT1N0M0 invasive ductal carcinoma with choriocarcinomatous differentiation received six cycles of adjuvant chemotherapy and is still disease free on the 23rd month after diagnosis, showing a better prognosis than most other cases reported in the literature. Conclusion : The reason for the poor prognosis for this type of breast carcinoma remains unclear. Standard chemotherapeutic agents administered for breast carcinoma may be used for choriocarcinomatous differentiation.